CompaniesTherOx

TherOx

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (6)
View all

Total Trials

6

As Lead Sponsor

6

As Collaborator

0

Total Enrollment

1,857

By Phase

NA: 3PHASE3: 1

By Status

RECRUITING: 2COMPLETED: 2TERMINATED: 1WITHDRAWN: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
NCT06438315
Hover over trial bars to see details

Recent Trials

NCT06438315Lead Sponsor
SuperSaturated Oxygen Comprehensive Observational Registry
N/ARecruiting
1,000 participants
Started: Aug 13, 2024 · Completed: Mar 31, 2029
NCT05156996Lead Sponsor
A Prospective Real-World Multi-Center Post-Market Observational Evaluation of Supersaturated O2 Therapy Using the TherOx® Downstream® System
N/ATerminated
6 participants
Started: Dec 4, 2022 · Completed: Apr 24, 2024
NCT04743245Lead Sponsor
Delivery SSO2 Therapy for 60 Min in Anterior MI Patients With PCI ≤ 6 Hours of Symptoms Onset Compared to Standard.
NARecruiting
434 participants
Started: Aug 2, 2022 · Completed: Apr 30, 2026
NCT04876040Lead Sponsor
Incorporating Supersaturated Oxygen in Shock
NAWithdrawn
Started: Dec 17, 2021 · Completed: Jun 30, 2025
NCT02603835Lead Sponsor
Evaluation of Intracoronary Hyperoxemic Oxygen Therapy in Anterior Acute Myocardial Infarction Patients (IC-HOT)
NACompleted
100 participants
Started: Feb 29, 2016 · Completed: May 17, 2018
View all 6 trials →
Related Companies
Zoll
acquired